<SEC-DOCUMENT>0001104659-24-090106.txt : 20240815
<SEC-HEADER>0001104659-24-090106.hdr.sgml : 20240815
<ACCEPTANCE-DATETIME>20240815160540
ACCESSION NUMBER:		0001104659-24-090106
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20240815
DATE AS OF CHANGE:		20240815
EFFECTIVENESS DATE:		20240815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLLEGIUM PHARMACEUTICAL, INC
		CENTRAL INDEX KEY:			0001267565
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-281571
		FILM NUMBER:		241212414

	BUSINESS ADDRESS:	
		STREET 1:		100 TECHNOLOGY CENTER DRIVE
		CITY:			STOUGHTON
		STATE:			MA
		ZIP:			02072
		BUSINESS PHONE:		781-713-3699

	MAIL ADDRESS:	
		STREET 1:		100 TECHNOLOGY CENTER DRIVE
		CITY:			STOUGHTON
		STATE:			MA
		ZIP:			02072

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COLLEGIUM PHARMACEUTICAL INC
		DATE OF NAME CHANGE:	20031020
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>tm2421486d1_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on August&nbsp;15, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Collegium Pharmaceutical,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Virginia</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>100
    Technology Center Drive<BR>
    Stoughton, MA 02072</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>03-0416362</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of<BR>
    incorporation or organization)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
    including zip code, of<BR>
    Principal Executive Offices)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<BR>
    Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2015 EMPLOYEE STOCK PURCHASE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plans)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Colleen Tupper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Executive Vice President and Chief Financial
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>100 Technology Center Drive<BR>
Stoughton, MA 02072</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(781) 713-3699</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jennifer
    L. Porter,&nbsp;Esq.</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shirley
    R. Kuhlmann,&nbsp;Esq.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwin
    Procter LLP</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President,</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2005
    Market Street</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Chief Administrative Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32<SUP>nd
    </SUP>Floor</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    Technology Center Drive, Suite&nbsp;300</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philadelphia,
    PA 19103</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stoughton,
    MA 02072</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(445)
    206-7806</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(781)
    713-3699</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule&nbsp;12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act.&#8239;</FONT><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Wingdings">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Wingdings"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Wingdings">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Statement on Form&nbsp;S-8 is being filed for the purpose of registering an additional 1,593,427 shares of Common Stock
of the Registrant that were added to the shares authorized for issuance under the Collegium Pharmaceutical,&nbsp;Inc. Amended and
Restated 2014 Stock Incentive Plan (the &ldquo;Stock Incentive Plan&rdquo;) and the Collegium Pharmaceutical,&nbsp;Inc. 2015
Employee Stock Purchase Plan (the &ldquo;ESPP&rdquo;) for which a Registration Statement on Form&nbsp;S-8 relating to the same
employee benefit plans is effective. Pursuant to General Instruction E to Form&nbsp;S-8, the contents of the Registration Statements
on Form&nbsp;S-8 (File Nos. 333-207744, 333-218767, 333-225498, 333-233092, 333-245649, 333-258752, 333-266778 and 333-273874) filed
with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1s8.htm" STYLE="-sec-extract: exhibit">November
2, 2015</A></FONT>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465917039543/a17-15260_1s8.htm" STYLE="-sec-extract: exhibit">June
15, 2017</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465918038906/a18-14995_1s8.htm" STYLE="-sec-extract: exhibit">June
7, 2018</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465919044558/a19-16762_1s8.htm" STYLE="-sec-extract: exhibit">August
7, 2019</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465920094654/tm2026488d1_s8.htm" STYLE="-sec-extract: exhibit">August
13, 2020</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465921104143/tm2124633d1_s8.htm" STYLE="-sec-extract: exhibit">August
12, 2021</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465922089335/tm2222417d1_s8.htm" STYLE="-sec-extract: exhibit">August
11, 2022</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465923089783/tm2323232d1_s8.htm" STYLE="-sec-extract: exhibit">August 10, 2023</A> are incorporated herein by reference except to the extent supplemented, amended or superseded by
the information set forth herein. Only those items of Form&nbsp;S-8 containing new information not contained in the earlier
registration statements are presented herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3. Incorporation of Documents by Reference.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following documents of the Registrant filed
with the Commission are incorporated by reference in this Registration Statement as of their respective dates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000155837024001526/coll-20231231x10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2023, filed with the Commission on February&nbsp;22, 2024</A></FONT>;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s
    Quarterly Reports on Form&nbsp;10-Q for the quarters ended March&nbsp;31, 2024 and June&nbsp;30, 2024, filed with the Commission on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000155837024007601/coll-20240331x10q.htm" STYLE="-sec-extract: exhibit">May
    9, 2024</A></FONT> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000155837024011586/coll-20240630x10q.htm" STYLE="-sec-extract: exhibit">August 8, 2024</A>, respectively;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant&rsquo;s
    Current Reports on Form&nbsp;8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form&nbsp;8-K and exhibits
    accompanying such reports that are related to such items) filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924000579/tm241446d1_8k.htm" STYLE="-sec-extract: exhibit">January&#8239;3,
    2024</A></FONT>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924046091/tm2411583d1_8k.htm" STYLE="-sec-extract: exhibit">April
    11, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924053506/tm2412857d1_8k.htm" STYLE="-sec-extract: exhibit">April
    29, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924059656/tm2414016d1_8k.htm" STYLE="-sec-extract: exhibit">May
    10, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924060235/tm2414016d3_8k.htm" STYLE="-sec-extract: exhibit">May
    13, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924063396/tm2414882d1_8k.htm" STYLE="-sec-extract: exhibit">May
    20, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924065119/tm2415470d1_8k.htm" STYLE="-sec-extract: exhibit">May
    24, 2024</A>; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924071070/tm2417144d1_8k.htm" STYLE="-sec-extract: exhibit">June
    13, 2024</A>; and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1267565/000110465924083126/tm2420341d1_8k.htm" STYLE="-sec-extract: exhibit">July 29, 2024</A>; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915033193/a15-2123_58a12b.htm" STYLE="-sec-extract: exhibit">The description of the Registrant&rsquo;s Common Stock contained in the Form&nbsp;8-A filed with the Commission on May&nbsp;1, 2015 pursuant to the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), including any amendment or report filed for the purpose of further updating such description.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All documents subsequently filed by the Registrant
pursuant to Sections 13(a), 13(c), 14 and 15(d)&nbsp;of the Exchange Act prior to the filing of a post-effective amendment which indicates
that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated
by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that
documents or information deemed to have been furnished and not filed in accordance with Commission rules&nbsp;shall not be deemed incorporated
by reference into this Registration Statement. Any statement contained herein or in a document, all or a portion of which is incorporated
or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as
so modified or amended, to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 7%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 92%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837020009387/coll-20200630xex3d1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837020009387/coll-20200630xex3d1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Amended and Restated
    Articles of Incorporation of Collegium Pharmaceutical,&nbsp;Inc. (1)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465917071469/a17-27884_1ex3d1.htm#Exhibit3_1_023250" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465917071469/a17-27884_1ex3d1.htm#Exhibit3_1_023250" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws
    of Collegium Pharmaceutical,&nbsp;Inc. (2)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Troutman Pepper
    Hamilton Sanders LLP</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex23-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Deloitte&nbsp;&amp;
    Touche LLP</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Troutman Pepper
    Hamilton Sanders LLP (included in Exhibit&nbsp;5.1)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included
    on the signature page)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1a.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated 2014
    Stock Incentive Plan (3)</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 7%"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 92%"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1b.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of Incentive
    Stock Option Agreement under the Amended and Restated 2014 Stock Incentive Plan (3)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d1c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of Non-Qualified
    Stock Option Agreement under the Amended and Restated 2014 Stock Incentive Plan (3)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837024001526/coll-20231231xex10d4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837024001526/coll-20231231xex10d4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of Restricted
    Stock Unit Agreement under the Amended and Restated 2014 Stock Incentive Plan (4)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837019004446/coll-20190331ex103e59c38.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000155837019004446/coll-20190331ex103e59c38.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of Performance
    Share Unit Agreement under the Amended and Restated 2014 Stock Incentive Plan (5)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1267565/000110465915074912/a15-22080_1ex10d2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015 Employee Stock Purchase
    Plan (3)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="tm2421486d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Registration
    Fees</FONT></A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&nbsp;Previously filed as an exhibit to the Registrant&rsquo;s Quarterly
Report on Form&nbsp;10-Q, filed with the Commission on August&nbsp;5, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2)&nbsp;Previously filed as an exhibit to the Registrant&rsquo;s Current
Report on Form&nbsp;8-K filed with the Commission on December&nbsp;4, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3)&nbsp;Previously filed as an exhibit to the Registrant&rsquo;s Registration
Statement on Form&nbsp;S-8 (File No.&nbsp;333-207744) filed with the Commission on November&nbsp;2, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(4)&nbsp;Previously filed as an exhibit to the Registrant&rsquo;s Annual
Report on Form&nbsp;10-K, filed with the Commission on February&nbsp;22, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(5)&nbsp;Previously filed as an exhibit to the Registrant&rsquo;s Quarterly
Report on Form&nbsp;10-Q, filed with the Commission on May&nbsp;8, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Stoughton, Commonwealth of Massachusetts, on this 15<SUP>th</SUP> day of August, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COLLEGIUM PHARMACEUTICAL,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Colleen Tupper&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen Tupper</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We, the undersigned officers and directors of Collegium
Pharmaceutical,&nbsp;Inc., hereby severally constitute and appoint Michael Heffernan, R.Ph., Colleen Tupper and Shirley R. Kuhlmann, and
each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in
the capacities indicated below, the Registration Statement on Form&nbsp;S-8 filed herewith and any and all subsequent amendments to said
Registration Statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors
to enable Collegium Pharmaceutical,&nbsp;Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements
of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys,
or any of them, to said Registration Statement and any and all amendments thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement on Form&nbsp;S-8 has been signed by the following persons in the capacities indicated
on August&nbsp;15<SUP>th</SUP>, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 46%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael Heffernan, R.Ph.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim President
    and Chief Executive Officer (Principal Executive Officer) and Chairman of the Board of Directors</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Heffernan, R.Ph.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Colleen Tupper</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice
    President and Chief Financial Officer (Principal Financial and Accounting Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen Tupper</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Rita Balice-Gordon, Ph.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rita Balice-Gordon, Ph.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Garen G. Bohlin</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garen G. Bohlin</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    John A. Fallon, M.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John A. Fallon, M.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    John G. Freund, M.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John G. Freund, M.D.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Gwen A. Melincoff</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gwen A. Melincoff</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Gino Santini</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gino Santini</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2421486d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="padding-bottom: 8pt; border-bottom: Black 1pt solid; width: 80%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Troutman Pepper Hamilton Sanders LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Troutman Sanders Building, 1001 Haxall Point</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richmond, VA 23219<BR>
<BR>
troutman.com</P>

</TD><TD STYLE="padding-bottom: 8pt; border-bottom: Black 1pt solid; text-align: right; width: 20%"><IMG SRC="tm2421486d1_img00.jpg" ALT=""></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">August&nbsp;15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Collegium Pharmaceutical,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Technology Center Drive, Suite&nbsp;300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stoughton, MA 02072</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Re: <U>Registration Statement on Form&nbsp;S-8</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reference is made to the registration statement
on Form&nbsp;S-8 (the &ldquo;<U>Registration Statement</U>&rdquo;) of Collegium Pharmaceutical,&nbsp;Inc., a Virginia corporation (the
 &ldquo;<U>Company</U>&rdquo;), filed on the date hereof with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
under the Securities Act of 1933, as amended (the &ldquo;<U>Act</U>&rdquo;). The Registration Statement covers an aggregate of 1,593,427
shares of the Company&rsquo;s Common Stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), including (i)&nbsp;1,274,742
shares of Common Stock (the &ldquo;<U>2014 Plan Shares</U>&rdquo;) pursuant to the Company&rsquo;s Amended and Restated 2014 Stock Incentive
Plan (the &ldquo;<U>2014 Plan</U>&rdquo;), and (ii)&nbsp;318,685 shares of Common Stock (the &ldquo;<U>2015 ESPP Shares</U>&rdquo;, and
together with the 2014 Plan Shares, the &ldquo;<U>Shares</U>&rdquo;) pursuant to the Company&rsquo;s 2015 Employee Stock Purchase Plan
(the &ldquo;<U>2015 ESPP</U>&rdquo;, and together with the 2014 Plan, the &ldquo;<U>Plans</U>&rdquo;). This opinion letter is furnished
in accordance with the requirements of Item 8(a)&nbsp;of Form&nbsp;S-8 and Item 601(b)(5)(i)&nbsp;of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this opinion letter, we have examined
the Registration Statement, including the exhibits thereto, the originals or copies, certified or otherwise identified to our satisfaction,
of the Third Amended and Restated Articles of Incorporation (the &ldquo;<U>Articles of Incorporation</U>&rdquo;) and the Amended and Restated
Bylaws of the Company, the Plans and such agreements, instruments and documents as we have deemed an appropriate basis on which to render
the opinions hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures,
the legal competence and capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity
of all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including telecopies).
As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have
not independently established the facts so relied on. This opinion letter is given, and all statements herein are made, in the context
of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection herewith, we have assumed that all
of the documents referred to in this opinion letter have been duly authorized by, have been duly executed and delivered by, and constitute
the valid, binding and enforceable obligations of, all of the parties to such documents, all of the signatories to such documents have
been duly authorized and all such parties are duly organized and validly existing and have the power and authority (corporate or other)
to execute, deliver and perform such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not purport to express an opinion on any
laws other than the laws of the Commonwealth of Virginia. The opinions set forth herein are made as of the date hereof and are subject
to, and may be limited by, future changes in the factual matters set forth herein, and we undertake no duty to advise you of the same.
The opinions expressed herein are based upon the law in effect (and published or otherwise generally available) on the date hereof, and
we assume no obligation to revise or supplement these opinions should such law be changed by legislative action, judicial decision or
otherwise. In rendering our opinions, we have not considered, and hereby disclaim any opinion as to, the application or impact of any
laws, cases, decisions, rules&nbsp;or regulations of any other jurisdiction, court or administrative agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing and in reliance thereon,
and subject to the assumptions, comments, qualifications, limitations and exceptions set forth herein, we are of the opinion that the
Shares have been duly authorized for issuance, and when issued, delivered and paid for in accordance with the Plans (assuming that, upon
any issuance of the Shares, the total number of shares of common stock issued and outstanding will not exceed the total number of shares
of common stock that the Company is then authorized to issue under its Articles of Incorporation), the Shares will be legally issued,
fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="padding-bottom: 7pt; border-bottom: Black 1pt solid; width: 70%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August&nbsp;15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

</TD><TD STYLE="padding-bottom: 7pt; border-bottom: Black 1pt solid; text-align: right; width: 30%"><IMG SRC="tm2421486d1_img01.jpg" ALT=""></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not render any opinions
except as set forth above. We hereby consent to the filing of this opinion as Exhibit&nbsp;5.1 to the Registration Statement. We also
consent to your filing copies of this opinion as an exhibit to the Registration Statement with such agencies of such states as you deem
necessary in the course of complying with the laws of such states regarding the offering and sale of the securities addressed herein.
In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section&nbsp;7 of the
Securities Act or the rules&nbsp;and regulations promulgated thereunder by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Troutman Pepper Hamilton Sanders
    LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Troutman Pepper Hamilton Sanders LLP</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm2421486d1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="background-color: white">We
consent to the incorporation by reference in this Registration Statement on&nbsp;Form S-8 of&nbsp;our reports dated
February 22, 2024, relating to the financial statements of Collegium Pharmaceutical, Inc. and the effectiveness of Collegium
Pharmaceutical, Inc.&rsquo;s internal control over financial reporting, appearing in the Annual Report on Form 10-K
of Collegium Pharmaceutical, Inc. for the year ended December&nbsp;31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="background-color: white">/s/ Deloitte &amp; Touche
LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Boston, Massachusetts<BR>
August 15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>tm2421486d1_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-138">S-8</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-139">S-8</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-140">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-141">0001267565</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-142">COLLEGIUM PHARMACEUTICAL, INC</ix:nonNumeric>
          <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-143">Fees to be Paid</ix:nonNumeric>
          <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_2" format="ixt:booleanfalse" id="ixv-144">Fees to be Paid</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001267565</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2024-08-13</xbrli:startDate>
              <xbrli:endDate>2024-08-13</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001267565</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2024-08-13</xbrli:startDate>
              <xbrli:endDate>2024-08-13</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001267565</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2024-08-13</xbrli:startDate>
              <xbrli:endDate>2024-08-13</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-178">S-8</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-179">COLLEGIUM PHARMACEUTICAL, INC</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word">
            <p style="margin: 0pt; text-align: center;">
              <b>Table 1: Newly Registered Securities</b>
            </p>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 90%; text-align: center;  border: 1px solid black; margin-left: auto; margin-right: auto;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation Rule</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 3%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-180">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-181">Common Stock, $0.001 par value per share - Amended and Restated 2014 Stock Incentive Plan</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457aFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-182">457(a)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-183">1,274,742</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-184">34.96</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-185">44,564,980.32</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-186">0.0001476</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-187">6,577.79</ix:nonFraction>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: center;">
		2
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-188">Equity</ix:nonNumeric>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-189">Common Stock, $0.001 par value per share - 2015 Employee Stock Purchase Plan</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457aFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-190">457(a)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-191">318,685</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-192">34.96</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-193">11,141,227.60</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-194">0.0001476</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-195">1,644.45</ix:nonFraction>
          </td>
        </tr>
        <tr>
          <td colspan="5" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-196">55,706,207.92</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-197">8,222.24</ix:nonFraction>
            </p>
          </td>
        </tr>
        <tr>
          <td colspan="5" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-198">0.00</ix:nonFraction>
            </p>
          </td>
        </tr>
        <tr>
          <td colspan="5" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-199">8,222.24</ix:nonFraction>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-200">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(3) Represents 1,274,742 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the Collegium Pharmaceutical, Inc. Amended and Restated 2014 Stock Incentive Plan (the "Stock Incentive Plan") on January 1, 2024, pursuant to an "evergreen" provision contained in the Stock Incentive Plan. Pursuant to such provision in the Stock Incentive Plan, as of the first day of each fiscal year, from January 1, 2016 until the expiration of the Stock Incentive Plan, the number of shares authorized for issuance under the Stock Incentive Plan is increased by a number of shares of Common Stock equal to 4% of the total number of outstanding shares of Common Stock on December 31st of the immediately preceding calendar year or such lesser number of shares of Common Stock as determined by the Board of Directors of the Registrant.
</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">2</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_2" id="ixv-201">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(4) Represents 318,685 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the ESPP on January 1, 2024, pursuant to an "evergreen" provision contained in the ESPP. Pursuant to such provision in the ESPP, as of the first day of each fiscal year, from January 1, 2016 until December 31, 2025, the number of shares authorized for issuance under the ESPP is increased by a number equal to the least of (i) 400,000 shares of Common Stock, (ii) 1% of the outstanding shares of Common Stock on such date or (iii) an amount determined by the Board of Directors of the Registrant.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td style="width:10pt;"/>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2421486d1_img00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2421486d1_img00.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !- *H# 2(  A$! Q$!_\0
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M)]>1YL?G8_9C_89SY6]?,QM^$N[.S.-OS>G-?NO#'A3PYC\IP^8Y_P"(G .
MQ.,HT\33RM<=9;@\;@:<X<\:.80ED&:0CC6G%U*%+$3CAW)4:E25>-:-+\UH
M^.W!&2YCFV5\1>"?TH.**F"Q\\)A<WX&X/X=P?#^*I4>6G4Q.%Q'$>8K,L91
MG6]JJ6(> P5"I1I*O0A4IUJ4Y?IO_P 1#7_!'O\ Z.]_\P#^U#_\Y2OUS^'?
MC_PE\5_A_P"!?BEX U;^W_ GQ*\'>&/'_@K7?L&IZ7_;7A+QCHECXB\-ZM_9
MFM66G:SIW]HZ-J-E>?8-6T^PU.S\[[/?V5K=1RP1_P #^B^/] N_C_\ \%2_
M MQ^SK^Q8_AG]FKXV:]X.^#>GC]AW]DA7\*^'K']H_Q+\/[:QFO$^#2WOB!H
M_"FG6FFF[\1W&K7;O$;YYVOY)+IO[D_V4+I;W]EK]FN\33]&TE+OX _!RZ32
M_#NB:3X:\/Z:L_P[\.2KI^A>'-!L].T+P_HUF'%OIFB:+I]CI.E64<%AIUG;
M6<$,"?.\9\!4.'N&,EXGP<<3#"9MG.*RB,,7F6%QM=5</D669[S>QPN5X&-*
M'U?-:$?:.O6YJL:M-4HJ$:U3]DX]S?@')/$K&^$N09?QAA^+,DX+X3\0LWQN
M=9AD.99#6X=XWA5ADF&RZOEF!RW'1S?#XC#U99G3Q.$^J4Z+A'#8BO4YI+\S
M_P#@O%_R9_\ #_\ [.,\'?\ JM_BW7S/\)/C/_P6CL?A;\,M.^'WP!\#ZEX"
ML_ '@NR\$:I=:9X0::_\(V_AW38/#5_<R7'Q,LYC+=:,EE<3//:6LI>1FDMH
M'W1+],?\%XO^3/\ X?\ _9QG@[_U6_Q;K].OV7O^39_V=O\ LA?PD_\ 4 \/
MU^HY?Q9A.%/H_P# -?%\'\)\81QOB#XAT*=#BO!8W&T,!*CA<BK.O@HX+,,O
ME"M64U1K2J3JQE1A&,8QDG)_PIF? ^.XW^E'XHX?!<?<<\!2R[PM\*<14Q/
M^89=E^)S..(Q?$M".&S&>8Y5FL:F'P\H/$8>-*%&<*]2<I3G%J"_/#]N?_@I
M%XS_ &</%?@S]G#X.> ;7XG_ +3/BW1/"<ES+/9WUYX8TG6/$MR+"PTO3_#>
ME75KK/B'Q!K<T,MQI^F1ZAI]GIMM?Z5<SW&J-)-IRX_[-WQ8_P""K^K?&+P>
M?VG/AEX&^'GP$BB\0ZO\1/%36?@FRDT?1M*\+ZSJ=F3)8^.]6U*Q\_5[;3;2
M:>73W%K;S33W310Q2RI\6_M"*K_\%U/A:K@.J^*?@LRAAD!D\#:?(A /0K(
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M^DV^O^(OB0+RVU?7[RWM9KJZMO"^E6UMI\7E)-"J/!=WO[L?M6?\FN_M)?\
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MJ;6C:G=W[IIB7:V.I-9_B_\ \%I?V=?%OP5_9"_X(N:UXN\,ZLVBZ!^RU:>
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MC!^R[_P4P_8X^(WQ*^+7B?XL> ?B3X(_:/\ $_@/2O%'PVU_0X;:_P#"5O\
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9I-4Z2E[.C3ITH^Y&T(16MKLHHHKE/./_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2421486d1_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2421486d1_img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !! (H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBOF[]K
MO]H/_AE?]GCXA_'G_A$O^$Y/@1?"NWPK_;O_  C0U1_%'C;PWX,3=K?]CZ]]
MB6R?Q$NHMC2;LW"VAM!Y!G%S#T_[.7Q7NOCI\"OA7\8+[1K?P[=_$7P;I'BF
MXT.UO)-0MM+EU*'S6LX;V:"VEN8XCPLSV\+,.2@KVI</9O'AVEQ7+"I9#6SJ
MMP]2QOMZ%YYOA\OI9I7PJPRJ/%)4\#7HUG7E2C0;J*G"I*HI1C\['BK(I\65
MN"(XUOB;#\.X?BNMEWU;$J-/(L7FE?)</C7C'26#<JN8X:O06&A6EB8JE*M.
ME"C*$Y^U4457N[NUL+:>]OKFWLK.UB>>ZN[N:.WMK:"-2TDT\\S)%#%&H+/)
M(ZHB@EB ,UXR3DU&*<I2:48Q3<FVTDDDFVVVDDDVVTDFVD_H6U%.4FHQBG*4
MI-1C&,4W*4I2<8QC%)MRE)))-MI)M6**XWPS\1OA[XTN+FT\'>._!OBRZLEW
MWEMX9\4:)KUQ:(&"%[F'2[ZZD@4.0FZ54&XA<Y(%=E6E:A7PU1T<30KX:K%)
MRI8BA6P]6*DKQ<J6(HT*J4EK%NFE):Q<EJ8X?$X;%THU\)B<-BZ$G)1KX3$8
M?%4).#Y9J-;"U\31DXR3C)1K2<9)QDHR5@HHK\_?VP?VXYOV6OBI^SC\*[3X
M:Q^-+O\ :!\5P^'O[>N?%;:#;^$;8>*_!_AZXN_[*B\/:M+K\\L/B>::&#^T
M]$CMY;2,O+<I*T:>MP]P[G'%6:4\FR+"+&YC5PV88R%!U\/AD\-E> Q69X^J
MZN)J4J,50P."Q-=Q<^>I[-4Z4*E6<(2\3BKBO(>"LEJ\0<2XYY=E-'%Y7@*F
M)6&Q6+:Q><YG@LFRRC&A@Z->O)XG,LQP>'4E#V=+VKJUYTJ-.I4C^@5%%<CJ
M?Q!\!:+KMEX6UGQOX0TGQ-J1A73O#FI^)=&L-=U!KAMMNMEI%U>Q:A=&=OEA
M$%O(96X3<>*\FE0KXB3A0H5J\XPG4E"A1K5YQITUS5*DHT:5:4:=.*<IU)1C
M3A%<TYPCJ>Y7Q.&PL8SQ.(P^&A.I3HPGB<10PT)UJLE"E2C/$5Z$)5:LVHTJ
M49RJU)-1ITZDFHOKJ*YOQ-XS\'^"K2&_\9>*_#7A*PN9_LUO>^)M=TO0;2XN
M=I?[/#<ZK=6D,L^P%O*C=I-H+;<#-;5C?V.J6=MJ.F7EIJ.GWL,=S9WUC<0W
M=G=V\JAHI[:ZMWD@GAD4AHY8G='4@JQ!S1*A7C2AB)4*T:%24H4Z\J-:-"I.
M%N>%.O*E&C4G"ZYX4ZTYPNN>$+JY'$X:=>IA88C#SQ5&$*E;#1Q%"6)I4ZC:
MIU*N&C7EB*5.HTU3J5</3IU&FJ<YM-*U11161L,DD2)'EE=(XHT:2221@B1H
M@+.[NQ"JBJ"S,Q 4 DD 5^/WBO\ X+Z?\$C?!GB77?">L_MB:%<ZMX=U2\T?
M49_#'PJ^/7C?P]+>6$[V]P^C>+_!7PL\0>$O$FG-(C&UUCP[K>JZ1?Q;;BQO
MKF!TD;Z,_;Q\)>,_BIX(T_X3>$_VJ_AO^S-I?BB*_3QQ)XFCT^3Q7XVT.X1+
M2W\.:3=7OBK0&TWPY>EKZ/Q)':6MQ=Z_']FTA[ZVT=M:TW6OR!L_^#?W5;VW
MMKZQ_:#^$]Y9W,<5S:W=K\"]*N[6YMY5$D4\$L?B!X+B&5"'1U9XI4(()4YK
M]=X.X)X%S#)X9MQIX@83AFIC*E6&!RQY3Q14K>RH3<98BMC\/PUB\LJNM9NE
MA\%BL5.E22J8FK"I4C0I_"8GQ,AD7$&9Y+4\%_$WQ'H8.A@90S+@;CGPBX<P
M]&OB(2J8BEB<'Q?FN-SN2HQE1I1J5,KRNA4JNM[+V\:<:M3]!_AM_P %U_\
M@E7\7?B+X!^$_P //VI?^$A\?_$_QKX6^'G@;0/^%(?M&Z3_ &YXQ\:Z[8>&
MO#.C_P!JZY\(=,T73/[3UK4[*R_M#6-2T_2[/S_M.H7MI:1S3Q_K?7^=U_P3
MDU.35_VNOAJVH:?X>GDTK_@I+I^CZ5,OA;PU;W&E:18?$SX6#3M)TRYMM)AG
MT[3-,,\[:5I]G)!::6\\TEA#;/+(S?Z(M<'B-P+A>#:/"6+P>(KUJ'$^5YIF
M,:>(JQK5L/\ V;G2RAPG.&%PM-^T;=6*A&:4;<TE+W3](XHS;A6EXE>(OAUP
MUEO$6$Q'A=F'#&49[F&>YGE.88?.<9Q9P9D_'6!Q&30RW+\OKX/"X++,WIY=
MC*690JUZV84:F(PTXX*4('YN?\%=?^4>7[07U^$W_J\/AI7QW^P)_P $M_V=
M;_X?_LP?M67GB#XL7'Q#2P\$?%E-&;Q'X77P6OBG3;J#6K%!IL?@I-:.EVVH
MVMO.EJ?$)G;RE26[D0NK?>O_  4X\ >,OB?^PS\>/!?@#PYJWBWQ7J%CX&U'
M3?#N@V4^I:SJ</AKXH>"?%&K1Z;IUJDEU?W<.C:-J%U%96D4UW=&#R+6&:XD
MCB?X4_X)\?\ !2[X.6G@7]F[]D+5_ /QBM/B_9VVB_"J;[/X8T&?PO!J5M>W
M%E%JMU?3^++37;73+?34CU/6WE\-K<Z4L6H(MM=16B7$_P"G\&8GCO\ X@#F
M>'\/<5FBQ>'\0>(*_%V'R3$8&.*I<*8G@7"4ZN(S*A7JJO#*:LZ&/A*O3A!.
M5.O"%64DX+^*O$'!^&?_ !-#DV*\5<'DSP.*\+.%\-P+B^(L)F4L%6XWP?B7
MCJM'"Y/B<+1EAJF>4:>)RNI##5:E1QA5P]2I0C!JI+XC_8P_9RTS_@JK\6OV
MF/BI^T[\1_B>UQX0UGPNV@Z1X0UW3;6"PA\;ZCXXN8-&L9?$VB^*8=+\,^&+
M'PW#I^C:+IEG:#;<F>>[+PR+=]!\6?@+X<\=_MV_L\_\$O\ 3_&'Q"T7]FWX
M/>'+YQ9/K5A>:WK>M:SX3\9_M >)O$=W)#I.GZ,VOZPNJVW@^RU"71IHM T^
M*6[TZR,ES?P7OM__  0'CD0_M?;T=/\ B<_!Q/F5E^=#\6]Z\@?,NY=R]5W#
M(&13/VTUUC]CC_@J%\,?VXO%_A#Q5XE^!WB/2K+3M;U_PYIZSQ:'K]S\,O$/
MPEO] DN)I$LTUJSTE=/\::;I^H7&G#Q'9F_T_2KEY]-U.:Q_9<PXCSNGXU<=
M\"99F<Z.&X<\.\R_XA1PU166X? Y9QC'@7)HY;+(<-5PE&@L[>&Q>;+ 2J5Z
MU>=:OB'04L1.<I?S[E7"?#M7Z/'AIXEYQD]/$8OBSQ8RG_B-_%^(>;XG,LXX
M!EXEY_/-X<3XRCC<1B9<.QQ>!R-YG"EAJ&&IX?#818B4<+3I0A0_X*'?\$QO
MV??V</V;-?\ V@_@+<^-_ ?C7X3ZOX)OV+>+=4UB#6[;7?&.@^$?.CGO7.HZ
M)KNFZAKUAK5AJ>D7UK!&MA=6C:?)+=VUU8>'7WQ=UOXY_MU_\$J/BEXBFEF\
M1^*/@A\%E\2W;>5&=3\2:+\7?C/X9\1:OY-M%!;VZZWJVC7FIBVAB2*WCNUM
ME!2($^^?\%"?^"EOP!_:7_9SUK]G+]GFW\<?$KQ_\8-;\#Z5!;6W@S7-,&EI
MHWC/0?%<=K;VE_;1ZIKNOZKJ.@V&BZ=I6C:?>Q2_;[FZ:^22UM[:^^=?CU\(
MO'W[#OQ&_P"";'QN^('@GQ-JGP\^#GPL^&6@_$K4=!M;74CH'CFT^)7C_P"(
MWC7P@]W#>_V/%J]G;_$":V\,'4-5T_3O%4^D7JV%^L5I?RV>O _^MM?A;)\!
MXFSS)^(6;1\9LIX0PW%-7#TN)L=DN9>&U+#PP%-8NK0QM3#8WB**HY;1QDH^
MVQJG#!\S24<?$?\ U%PW&N?9IX.T\H7A5D<OH^Y[QYB^"Z.*K\'Y;Q#E'B]6
MQ53,ZSP-'$9?2QF7\)S>(S>O@(2>'R^5.IF'(I-R_9+_ (*\\?\ !/?X\X_Y
M[_"K_P!7-\/:_#G]I;PIIWC[X3?\$>/ VM3WT&D>-/!G_"):K<:=+##J,&F^
M(O''PZT:]EL)[FWN[>&\BM+R1K22>UN8(YEC:2WFC5HF^MO^"A'_  4Q_9Y_
M:9_9GUS]G_X$0>//'/C_ .*^N>!=/MK#_A#M4TPZ2NC>,=!\5"'RKE&N=9UC
M4KS1+71-/TO0X-0\^:^DG-RHMXH[K@OVT_@9\9/@M^S_ /\ !,OXGR?#OQ#X
ME_X9G\.Z?=_%S2]*LY;H>#-574OAOXQTW2_$4U@E])IMM+?:9KGAO4-=:&31
MK+5;&VA:\,NIZ=%=>'X1Y5G/ ^1< 9/Q+AJO"W$6:^(?B7B\DP&<U,-EF857
M7\)<5DV68N%'%XE2HTJ^?K"X'!UL0J=*OC71I4O;2G"G5^D\=<ZR#Q(XE\4,
M_P"$,70XUX4R3PJ\(,#Q%F?#]+%YSE=%8;QTP?$&<8&I7P.$E'$5L-PN\;F6
M/P^%=6MALN6(K5_J\*=2K1^R/&7[#_PI_P""</[/W[47Q_\ V?\ Q7\5IOB/
M<_ OQ#X&T_5O%_B?0;O_ (1VW\2:SH*-K6@MX;\)>%[JSU[3;^VT_4M/O9+J
MX6WN;"(I""68_,?[!?\ P2T_9S_:7_9#\,_&7XHZC\0+WXB_%6X\>SIKNF>)
M!8IX4?0?&_B;P;9R:?826MU::Q<SOX>_MF_N/$$>H?:;B^DM4C@BA61_:_CQ
M_P %%?@G^V;^R+^UKX'^%?A;XKZ/K'A?X-)XMU:?QQX;\/:7ID=@OC7PGI7V
M.*[T+Q?XD=M2:?4%FC@D@BADM;2^F6X/V?8WU]_P2-5E_P"">G[/H8%3CXK'
M!!!P?C=\22#@\X(((/<$$<&OCLWXC\5^$/"WB#/,_P UXCR+Q#QGBCPOEF:9
MGBZF$H9_6R'"\$YEC\HP&(KX>C6C_9T:BGB*6&CRTJJE4=:G456?M?OLBX2\
M$./?&CA;AOA?).$N)?"G >#'&><Y+D^!HX[$<+X?B;&^(N497GV:87#8NOAY
M?VM.DZ6%KXR7/6HN%)8>K2=&#H_B;_P2N_8I^$_[9\'Q>\1?M!:CXX\5Q?"_
M_A"?!WA#2+3Q9?Z;9V=CJ=KXEN)S-<JL^I_9]/73;*+0]-L;ZQTRQ634#<6=
M\;BW^R?47_!./2D_9@_X**?M>_LU:/XQU,?!3PKX"\4^*A#XFU.UBLK!_#'B
M'P#=:+X@UF[D2TT^&\T3PQXLUK2M5U>.+3H+Z#%[>QI':VT=MT/_  0)CD3P
MC^U!O1T_XK/X>I\RLOSIIGB_>O('S)N7<O5=PR!D5Y%#X2\1^./^"D'_  5%
M\%^$[&?4/%'B_P#9'^/WAGPYIT(19M2UO7_#/PNTW2-.A>9HX4DU&\NH+2*2
M21$0SB0N N:_1>,<XS/B#CGZ0O!.<9W6_P!4\%P3P_4R_+\2\-+*L@KU,[\.
MZ<\WP.%G1I4,)B,(L[S3'5<1"I3E-RKRKU5&4YP_*. ,@R;A;PU^BKXC9#P[
M0_UYS'Q$XGI9KFN$CBX9WQ/AJ?#GBQ5IY%F6,AB*V)QV%QTN',ERZCAJE*K&
MFHX:&&H.<:=.IXEX]^'W_!%R#QKK%O?_ +17[5?BO4-0U>^NM9\7>'8M*U;1
M%U2\OIYM0NEU*^^$$%UJZ-<O)<'4-+LM8M+U'$]I=7F_<W7_ +"OQX\3?#W2
M/^"C'PI^$WQ>\5>.?A#\//V;/C3\4/@9XIU2;6+"_P!$N_"$-W8^%_$N@Z7J
ML5G<^%[[5+7Q%9ZEK=E#IVF>9J^CV=PUE:31LE=5^Q5^WS^S-^QU\"['X"?M
M ?L\?$W0_B[X:\0^+3XWGB^%_A*:^U^35==OM1TZ7Q#%XNU_POXBM=4TK2+N
MT\,R:;J6G3)!9:+:/!=-'<&UM?(?V;-3T+XD>-_^"L?Q?^&/@W5O#GPB\1_L
MF?M(3^'89= MM&LM"7Q9/!K>A>'[FUTB:\T32M1N+#2]6N;?2+"]FB2#3[LV
MI:"V8K])F."S:KD_'62\3Y=QWF?#N53X1I\.<1\=YWPIGW#W$%>CXA<#X3"Y
MGPY0RS),#++<1CLNQ.(="CAL9BL-B,GQ%3!U*52I[6-3Y#*LPR*CQ!X:<0\&
MYKX:9/Q7G=/CNKQ;PEX:<.\<<,\4\+8;$>%7B1C\;D_%N)SGB+,H9MA,MS;"
M86.)KXO 8+&87/\ "4L?2K4J7L94?>O^":__  3:_9Z_:B_9WN?C;\<7\<>*
MO%_BOQKXKTV V?BR\T>UTNRT::WLUN2;:-[W4]9O;]KZ^O+_ %.\NK:2.6SM
MTL(WM[FXO=[_ ()JV&J?L]?\%)_VDOV5_"GBGQ+J?PBTK1?'R:?H.MZD;F);
MWPYXB\*7'AW7KFWMXK73W\166C7]]HEWJ5I8V2ZA!>322VZA+6*W^Y_^"+2L
MO["WA3<K+N\?_$8KN!&1_;FW(SU&X$9'&01U!KXR_93CD7_@MM^U"2C@#2?B
MBQ)5@-KWO@<JW(^ZP92IZ,&4@G(K\XSKBCB#B'.OI3\-YWF^+S3(,CX9SJOD
MF3XV=*MEV45LJXER##9?5RS#/#QA@JN%H2E3IU,-*$[3FY2<IRD_UKA[@SA?
MA;A[Z%/%W#F0X')>*.).,>'L-Q'G^7TZ^'S7/</G7"'%&,S2AG.+CBI3S&CC
M<3"%6K2Q<:E.].FHQ481BOS9_P""'G[!/C[XT?%/QQ^T5XJCU'P7\)OA-^VI
M\0O'GAR^O]+U"VO/BCXA\-ZYX?N]*M_!MQ<VBZ?>>&M#\4>%OLOB_74GEC2>
M&3PYID=QJ9U6Z\/?VIU7M+2TL+6VL;"UM[*RLX(K6TL[2&.VM;6V@18H+>VM
MX52&""&-5CBBB18XT5410H JQ7\H\6\99KQ?6RWZ_*%/ Y)@ZV7Y-@J<8<N"
MPF)QCS#$QG548SQ-?$XV4\16K5-?X5&E"%&C!3_TASN&4YGQOQSQU@LKCEF:
M<?YIE&:YZEBZ^+=>OD/"^2\(94E.LH0IQP^39)AX>RH4:=)U\1BJOORJ)Q**
M**^1, JK>V-EJ5I<Z?J-G:W]A>0O;W=E>V\5U:75O*I62"YMITDAGAD4E7BE
M1D=20RD'%6J*:;BU*+<91:E&46XRC)--2C*+C*,DTFG&2::3332:4HQE&491
MC*,DXRC**E&49)QE&49*491E%N,HRC*,DVI1:;3_ "K_ &V_^"@?[ W_  2A
ML_"VJ?$_PM!HOC?XG1ZI-X:\ _ OX9^%KCXA^(M%T::UBU?7+T_:O!^@:7H=
MK>WUI:PW'B?Q1I3ZQ>O=1:#;ZJ^DZT=-^!-)_P"#H7_@GGK&KZ9X>\>?"3]K
MGX<Z!XDG6PF\3^/?A+X!N_"MKI-V1#<ZCK%CX9^+'B?Q)>Z9'!*7O+;0?#'B
M*ZD@+I!9W3LL3_+?_!2#0=#^(_\ P<K_ /!-KP=XOTZUU;PYI/PE^%FKQZ7?
M*MS87&J>'/B!^T9X[TFYGM9@T$C)KNDZ0SQ,CQW"6%NDJR+E#^D__!QUX6\/
M>(/^"2/[0NK:UI=G?ZEX&\4_ SQ3X2N[J%)9]$\0W?QL\">"KG5-.=@6M[R;
MPIXP\3:*\T9#MI^KWUN3Y<[@_I]#+LBE5X/H9S0SK-,SXIPV&Q%?-'GN(ISP
M*Q688C 82-&E5HXV>(^KK#PJ-UL7'=QAR6BE^Y9#P5X;950\,.'\PX<S/$XO
MQ"P.&QN)QN59QA\BP&3K.<[S#*,-#!Y+@LBE@L7[)X:&(Q4L3*F\0ZE2,^:]
MG[W^UK^W[_P3[_X)J_#;X=?'#Q?HNB0P?':TFN?A59? /X=^%-1\8?%+08M.
MT37=1US0[R"?PKH4_ANTT_Q%X;OKK5-:\4:=8S?VYI"VCW=Q=Q1U\->'O^#G
MG]@.Z\4>'?#_ (^^%7[8'P:TKQ+?V]M!XW^)/PC\'1>%=,T^>2.-M<U2'PG\
M4_%?BR?3;42++=_\(WX6\17:Q?-!;7#$(?YLOC-\9_B3#\</^""OBI?A?K_[
M1^K_  P_8L_9N\2>!O@-IE[<6=U\0->\$_'WXS^'?#V@:28- \3"WU+6='^&
M7@6RGNH_#6LS7L.BV"W-I>B-,_JS_P %'/VO?^"B'_!0_P#9,\>_LNZK_P $
M-?VC?AYJ/BW6/ NN>%OB7J6L^)OB!<?#_7?"/C30]?GUG1]"NOV>/"#)J.M>
M'+/Q!X'GU"U\3Z--::+XLU?S9KNRDN],OO9EPA@%+*EG$<7FU7,)XN./SG%\
M783+ZN7X>AFF/RW#NC@LSQ%:OCHX?#X2.(J?O9TY3E/#TE"T8'U66^#/!N08
M;AK+L5DE+$8?.,1F\\USK#<;<-<%4,BP]/B3.,FHXC!<-UZ."CFDZ.%RVGF.
M.JQI3CB<1.KA83<XPB_WP_;O_P""N?[''_!/?PS\,/$/Q>\1^)?'=Y\9=,E\
M1_#CPI\%-/\ #_CGQ!XC\&1064__  G<5QJ/BCPSX6M/!]V=2L(=%UB^\2VP
M\2RS7!\-0ZO#I&N3:9^?'A7_ (.A_P#@GQJWBGP_X=\:?#7]K;X1Z;XAU&VM
M4\:_$#X6^"#X6TC3[B6.)M<UB+PA\5?%7BN33+02+->?\(]X6\0W:19-O:W+
MD(?R"_9P^&?C2V_X+O\ _!,G]GC]IG1K77=?_9R_8P^"/@QO!OB/^SM>M/!/
MB3X;?L5^-/BGHVC1-!)>Z7/J'P]^*%[+JVG:A87-Y:P^(=(@U33;R>.*VN#^
M^?\ P<;^#/"OB?\ X))_M$Z_K^AZ=JNL_#OQ#\#_ !7X(U*\MHIKSPUXBU'X
MY?#OP+?ZKI,[J9+2[N_"'C'Q/H%Q)$RF73=8O8'RDI%>.\@X7R_'\.9)C,+F
M&9XC/Z="K+-L+FRPE&A3S#,L=@L#/#8..#KTJ\84L/A\14E5KI5?:R4/<4'+
MR7P9X>Y)G/ W"6:Y;G6?X[C*AA,1/B7+^)%EN&PE'.L]S?*<HJX'*J>5XO#X
MN%'#X+!8RO+$8N,,0\1-4OW:IN?UC^W7_P %3_V1_P#@GO\ #WX>_$'XT^)]
M=\4)\6DDN_AAX3^$>GZ1XS\4^.M#MK73KZ^\4Z&;W7_#_A<>%K*UUC2)FUS4
MO$^GV=]_:EE'I+ZC-(T:?F5I'_!TG_P3^GUK1]-\6_"/]L3X=:7K5[;PP>*O
M%GPL^'CZ%9:?/+'')K5_!X>^,&N^(9[&SCD%S=1^']"U^^,"D6=K=SM'!)^&
MG[(URW[17_!2C_@A)X9^,-O%XLT/PE^Q9X-M=*TK6HTN['9\'-2_:NU_X=S3
M6<ZM;S/I=UX)\(>4TD;FX@T73HYC*L2 ?TY_\'"GA;PYXD_X))_M1WFO:/I>
MIWOA%OA'XH\+7VH65M=7?AWQ%%\:?A]H@UC1+F>-YM+U.XT/7-<\/S7MD\-S
M-HVN:MI3R/9:E=P354X<X;RC,,@R+,\%F.8XW.JC5;,,/FCP-/"0KYQCLJPO
ML,''!XB%=TXX2%>LZM://*<J<;1C%NZW _ ?#.=\&<(9_E6>9[FW%5:4<5G>
M"XA>44,MIXSBC..'<O\ JF5T\LQE+%RHT\MI8S%/$XJG[2=:I1A:,(-_2?[:
MW_!4O]D+]A#X0?#?XS_%OQEJ?BO0?C+!!?\ P>T'X36FD^,O$_Q/T273-,UJ
M;Q/X1BN]<T'P_<>%;+2-;T34+KQ'J'B'3M(\O6]&@MKNXO=6T^UN?S9T'_@Y
M\_8%NO$/A[2/'/PF_;#^$>A^)KVV@LO'/Q"^$G@J/PM9V$\D22:UJ">%OBKX
MG\2W&G6:3+<77_".>'?$5V+?+06T\A2)_P"6K3OC!\2+7XN_\$.O&1^%'B?]
MJKQ!\,_V8-$UGP/\![75;V/4?'>H^ /VT?VOM!\(:!HTP\/^+GM9=/T7X?\
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MQ6:Y+Q++-\[QV*EA*\L;@,-B7&>,P^/I^VPN/P=+%U'4P[A+VE.'\UW[6?\
MP09\17W@']A[Q3^PA\:-&^$G[4/[!O@OPCX)\">,_B'8W4?A7XB6_AGQ5=>/
MU\1>(1INC^-%\/:\OQ#U[QOXR;3CX4\6>&->/C+5?"VN:<NC?9[JWQ=+L_\
M@Z,74-.TO4M6_8N:P%Y:65_XD>#PG)FT$\<-UJ[VEI96LSYAWW1M[;2+>5O]
M7#8Q.5B7^FNBO!AQAF4J%.AC\)D^<JC+$/#ULXRRGC,3AUBJ]7%5X4L0JV'G
M[*6)KU:T:4U.%.<WR*,;17QM+Q.SV>#HX/.<LX7XI6%ECI8+%<3Y!0S3'X-9
MCC,3F&+I4,;'%X&L\//'8O$8J&'K*K2HU:LU24*;5.'X$_MH?\$XOVC?CO\
M\%COV'_VW_ L?@4_ [X!^!_A[H/C^;6?%$FG>*XM0\*?$;XP^+-172/#Z:5<
M_P!I13:9XVT2.SE%] )+PW<4PMXK?SW_ 'VHHKQL=FN*S&AE>&Q'LO9Y1@?[
M/PGLZ?)+ZO\ 6*V)_?2YY>TJ>UKU/?M#W>6/+I=_+9OQ%F.=X/A_ XWZO[#A
MG*/[$RWV%'V4_J7UW%8__:9^TG[>O[?&5OWO+2_=\D.3W>:11117FGA!1110
C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140158464807616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 13, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001267565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">COLLEGIUM PHARMACEUTICAL, INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140158464474528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 13, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457aFlg', window );">Rule 457(a)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.001 par value per share - Amended and Restated 2014 Stock Incentive Plan<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,274,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">34.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 44,564,980.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 6,577.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(3) Represents 1,274,742 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the Collegium Pharmaceutical, Inc. Amended and Restated 2014 Stock Incentive Plan (the "Stock Incentive Plan") on January 1, 2024, pursuant to an "evergreen" provision contained in the Stock Incentive Plan. Pursuant to such provision in the Stock Incentive Plan, as of the first day of each fiscal year, from January 1, 2016 until the expiration of the Stock Incentive Plan, the number of shares authorized for issuance under the Stock Incentive Plan is increased by a number of shares of Common Stock equal to 4% of the total number of outstanding shares of Common Stock on December 31st of the immediately preceding calendar year or such lesser number of shares of Common Stock as determined by the Board of Directors of the Registrant.
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457aFlg', window );">Rule 457(a)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.001 par value per share - 2015 Employee Stock Purchase Plan<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">318,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">34.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 11,141,227.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 1,644.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(4) Represents 318,685 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the ESPP on January 1, 2024, pursuant to an "evergreen" provision contained in the ESPP. Pursuant to such provision in the ESPP, as of the first day of each fiscal year, from January 1, 2016 until December 31, 2025, the number of shares authorized for issuance under the ESPP is increased by a number equal to the least of (i) 400,000 shares of Common Stock, (ii) 1% of the outstanding shares of Common Stock on such date or (iii) an amount determined by the Board of Directors of the Registrant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457aFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457aFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140158464800736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 13, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 55,706,207.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">8,222.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 8,222.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "D@ ]9_;PMCU "   Z!@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(6576_:,!2&_XJ52;MJFQ"^*A8B009M5& (RC9IVH4)!V(UCC/;:>#?STX@
M8U)P;XB_WB>/C3EX!>-O(@:0Z$B35 RM6,IL8-LBBH%B\< R2-7,GG&*I>KR
M@RTR#GA7AFABNX[3LRDFJ>5[Y=B2^Q[+94)26'(D<DHQ/XTA8<70:EF7@14Y
MQ%(/V+Z7X0.L06ZR)5<]NZ;L"(54$)8B#ONA-6H-QGV]OESPG4 AKMI([V3+
MV)ONA+NAY6@A2""2FH#5XQT"2!(-4AI_SDRK?J4.7K<O]&FY=[67+180L.0'
MV<EX:#U:: =[G"=RQ8IG..^GJWD12T3YB8IJK=NQ4)0+R>@YK PH2:LG/I[/
MX2K0=FX$W'/ +;VK%Y667['$OL=9@;A>K6BZ46ZU3"LYDNHO92VYFB4J)_UU
MOJ5$Z"/V;*EX>M2.SMEQE75O9$?YX0&UVG?(==S._W%;:=0N;NWBEKSVAR[H
MUTS-H5 "%;^;Q"I0IQFD+_) 9#B"H:5NJ@#^#I;_^5.KYWPQ:+9KS;:)[@>0
M2HX3%*8[.*(7.#4)FA&.X[3<7K_;ZQI\.K5/QPA;P8$(991*M, 4FFS,@.#;
M;#9Y"C=SM'P>K>:C8+)Y#8/1[ Z%B\ @V*T%NT:^_OF@UU/6J&:.KN\?#0*]
M6J!GIOR[6+<T/@ 8-?JU1M]\#@!H<HS)ELB;'F;"Y.?]-)R%BR<TG4S634KV
M52G0576.^8&D B6P5T3GH:_.FU>5JNI(EI758<NDJC5E,U;%';A>H.;WC,E+
M1Q><^N_"_PM02P,$%     @ I( /6<D@L]!_!P  11\  !@   !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6SM65MSVS8:?<^OP&C;76M&D02*NCAK>\:Y=+>=
MV:[&2MIGB(0D3$B" 4 YZNR/[P%(B71"@;:W[5->;('$]^%\=QSIZEZJCWK'
MN2&?TR33U[V=,?FKT4A'.YXR/90YS_!F(U7*#)9J.]*YXBQV0FDR"L;CV2AE
M(NO=7+EG2W5S)0N3B(PO%=%%FC)U>,T3>7_=H[WC@SNQW1G[8'1SE;,M7W'S
M(5\JK$8G+;%(>::%S(CBF^O>+7WU.IA: ;?C%\'O=>,SL::LI?QH%S_&U[VQ
M1<03'AFK@N'?GK_A26(U <>G2FGO=*85;'X^:O_!&0]CUDSS-S+Y5<1F=]U;
M]$C,-ZQ(S)V\_S>O#'( (YEH]Y?<EWM#G!@5VLBT$L8Z%5GYGWVN'-$06(S/
M" 250.!PEP<YE&^983=72MX397=#F_W@3'72 "<R&Y6547@K(&=N_KO9<"6R
MK;X:&:BS#T=1)?JZ% W.B-X6VR&ADP$)QD%(/JS>DHOO^D3OF.)?:!L!U E9
M<$(6./5A![)7A+9A\PK;7'ZE<Q;QZQZ257.UY[V;O_^-SL;_]$";G*!-G/9)
M%[0V8),_ 5AX A9Z??8#YV2I^%[(0B<'LF0B;H/H5[)AB>8>,-,3F*E7SUV1
M<!).YQ>LWP;"+VQ4X<,P.V&8>=6L>%0H80[D_2'G;2C\XN\^%1#VX)B?<,P?
MA^--PK0F[X5)6N'XM;R1:8I.MC(R^C@@WXV'XS$E.5-DSY*"DYRKLOS(2W*+
MSAGSF+ L)G=<&V:P",8T+*7)CUG$,]L0R3)AF<?"Q<G"A1?;;2J+S."LK="&
M*YSVO]9>4-I9ZIHZ779P[&]H, _G87 UVK> N#R!N/2"6"J92XVS_\,^B[1(
MR;%2414B*CWT(1.F#5*I>=: - F'E[-V0'1<]]>Q%](1R>UVJ_@68?@"4VO?
M+57.&UC"<#H++Q?CX>2,BVBCX]/.)G$'(*TGEZ*+QLDVRY W\W.>J/LY]3?T
M*D/DIDH2Q=Q<!IQ6),%7/IA-Y_/A_/(,CKIY4V\+/G5O\K,\XX1GM/ +VD=-
MX9(1214S%!?FN-F1L@?2&2E0C8J8'2=5*Q!<D]O(N8->3C!%F2:L+-H!]@G]
MT$LK6\%X#0&X#/<1LGJYL 66)&3-<0_!RY@822*YQT$L.Q 6Q\+*LJ0J1'M6
M5+80W=E"+BS67K/C]/H#JP'WGP3(D-)+;$SAA\*(B"4#VU.&L(/\(M169(+A
M,)7+RH!2W]&FS%AM]SL1[0 ?H#@16A=L#7?5KF)K&/,R8]:T'&U*D_4!5T&F
MH0](K)'.$!*+O8CANT&UUGDBS !;(Y8+PQ+Q6PE"*B*A&#:*5"2PVD+1K+P@
M<N1%9-NDC1PNL X"5'"1F])UN(L"6JFJQ ZOXOJGB4#H,_R-+#INEU8X*](U
M#H.L74$E^G 6V]2K ]+T\'%G[:4A618*?D'<$=MC-EU$_;,)526/:B://B5/
MF3 8\'6B &S,T;%QN;3=B9VJ5&2VCVM8AZ.18]+6#=P#)VJ9("(-9!:'/S'L
M\)F2=VF>R ,:4&DOC(MVUF%V"%4I\FZU7/;ZPQ<O+H(^>:>-2-WL$N>*"Q<,
MN,/-N>-ZU[<(.6Y H"T.&[#:P>#"R)*H2. 8A*&,<,-3&T"39?!PUQ?Z&!$&
M7X&D')<[W/7=D2 U)+=M7'\=NW_H!]5F"UQQU(.U!@_?8_//3,?L$_E7(M>H
MTI7C*IA=ZB-W=8X;-A@ N2ROV-8EDSX.<%TG0USH $-S@*GYZ'S"DAERCSC:
M]E!V#+NCDF<%,E^)W_#">LZ5I'5WG6P=07[:M:.*>-NK7M\ZX">6%>"*,-1Y
M8/ @YR#?XX@+YBK/>@B#W M'%E&H!GRT3!I7(2T'/*PL7:"8:PT>.=>H*[]N
MA$)X8G:P#SB#BHW0< 8Y<*8&9*-D^M $-PB,2)PT_YR+*NTJ?>WG/>PDCXY4
MJ\.%/C6IV#93]K7F+W.(?RI@$7P4?G_$:21Z:D/R,9TM(V_12IW$A&IS5"52
M-'>!-$&QYK;9.B7P(?((_=DZTC4<&Y^$:TS;;L0(T+&CE5;:@UY+IF*[]:W
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M"6VZT4T/YOD#:1/,?B:$?@EL2_8/:O(74$L#!!0    ( *2 #UDJQB!D"0,
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M4$L! A0#%     @ I( /63B:TQ7O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ I( /69E<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "D@ ]9_;PMCU "   Z!@  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ I( /6<D@L]!_!P  11\
M !@              ("!E H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+
M 0(4 Q0    ( *2 #UE7D^2,*@(  %P%   8              " @4D2  !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "D@ ]9*L8@9 D#
M   ;$   #0              @ &I%   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( *2 #UF7BKL<P    !,"   +              "  =T7  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( *2 #UE2<6^U70$  $@#   /              "
M <88  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "D@ ]9NVSJ[+H    :
M P  &@              @ %0&@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " "D@ ]9IOQ*6R,!  #?!   $P              @ %"
L&P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "P + ,H"  "6'      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2421486d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm2421486d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm2421486d1_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm2421486d1_ex-filingfees.htm">tm2421486d1_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2421486d1_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm2421486d1_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2024": 2,
    "http://xbrl.sec.gov/ffd/2024q2": 5
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 28,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457aFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421486d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457aFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421486d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421486d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421486d1_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-24-090106-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-090106-xbrl.zip
M4$L#!!0    ( *2 #UFC.9CK: P  $!)   =    =&TR-#(Q-#@V9#%?97@M
M9FEL:6YG9F5E<RYH=&WM7.MSVS82_]S\%3A>,XEG]""IEZ4HZBB.W?J:N)[8
MN>FW&XB$)$SX"@#:4O_ZVP5)B:2HAQT[<9LT,XU(+!:+W=\^\&"&ORQ\C]PP
M(7D8O'YA-<P7A 5.Z/)@]OK%^.KD_/S%+Z-GP[D",B -Y&MCKE0T:#9O;V\;
MMZU&*&9-J]_O-Q=(8R1$@X7'@T_;2;%U13H1'B^0XAM-;)MFJ\D#J6C@L#R]
MN^Z0)^XVD\:,E,NP;5N]7<P3BE6'Q39:"P4!L=F?;SZ\6Y.K:OHU:5,)&LAI
M*'RJ0,7(J5,W[;K=S3&I2^84&,%S8Q;>[.5S7&]9&9\-C1=GBLT3*E=J=%E)
MA]F8T  ]['9&.)VZU830H D_V\;H&2'#.:,N_H"?BBN/C4[_K)^=OSN_^)6<
MG9Y>#9O)6R1M9K3#2>@NTTXNOR%2+3WVVG"YC#RZ') @#)B1M ,%7PRP(Q/9
MF_0==UT6K-\E;Z'K1>PSP1T24!^8@KR#,U#@=600)PP46Z@/;/K:$(Y!.,R1
M+V[J5NO8&%W5CX?- H>#>%_%$Y]+&>SFW[\W_S/&3A=S/N%JYPAMT]C0_-T&
M P0,3@.PUO*$!8 [[SQPV>)WMMPUJF6,3-.T[&ZOT^W<?\0/;,8E8EU=0,NN
M 0%U)W^\>W?ZZ_G']^3RM_&']^.3TX_7YR?C=S5R?G%R'Q5?"G8CO>6E>^;-
MBF.'TZGP_@?.EK@@"J$&DS#T& VFU$._6HO6,D9@+$E42":,7%+N/H8P]F'"
MM \71C>4O0GE$VS*!.0%)@N28TP92&?.? IR$1W6!W.!(F+ D-LC!OZL)S\;
M"^D::5^UC&#RDON1QXQF2; J(1+A9!B+LFPZK0Q2K6EU 'SR%"L:IH%7;%HU
M<A>;IYP)HB?**N/TR?GO1?B7.Y<&;FX?.1TW LN$[A:A("$*]98J-D(58AJP
M6AG/=5MU7Q:X6WIF+96B;LJ3M:0JWJ/\S'^>B 76JF0S'TC*K6F[RS4DW??,
MG\#X+@=:72EI!_UC"H"$0FF\X-+8Y( I#>(:9O"+<&0-F[FGS>&:F^-MB-S<
M(?-WBRG[^\64_0-395'O@ZDXX F@/EZ]K0:3SZB,!1NERX4!$&9LLZ:*$9'O
MKN$BZ+=[O'1.\/,!AKN:4TB5APPH->6=ATRS="D;)T5%KFP'T/*;=<V_HE-T
MXK%L!7#+734?D'[_^2NH<@)5GU*?>[ B& M.O1KYC7DW3'&'UHB$A1&LH 2?
MIJ22_\4&Q#8C]8J@R>O4X[-@0!S ,1.O<AH8JH)##)4+=98G(PK>" N@5):(
MNK@>KD]"I4)_0!H=YI?5&&W >#(ZH9X3>WJ]1L(I.>/@J#,"Q1BYQJF"@B=E
M$$=%+2LWK]V\L!62;Y/6/E#<S?AQ[U54;^\J*IG1WW#^]UBJ]/KW7ZI\F9[@
M-R*MTN^VZ0O\9K'VD:)73KV0JI4CD=1)+=-\7O0TCTW!]TC1TU9,[N7.5C=:
M&$63SS..-TQ@7R\;/IE*I?-G,O=1Y-M0N/5;02/H(AC]5,<7&U#)1O&IF''@
M=$!<66%*.SJQ!N2"W7I+DD &5C$NN6).++CB!X6!^0'FW;#5O=4,+RKMW"^;
M.6L'A0L([] [6A 9>MPE$X\ZGUZ11&=UQ,. T%B%JU>"S^;9NVJ<3(##3(1Q
MX-8A*(=B\._^^.WXK+L-!:F4]O.R)8;_JM?)FW?CB]])O;Y=LU7,+'.3VQ<!
M(C7[DEQ#378WRW]=^4X\*B6YQBV[0P+0UY83LV@^OWZ(O:>HSK$/^%4YOW\
M&3L/+..E"*-00DAZ3Q?<CWV2K4'()20C1BYAE?(1"KTG*'HF\7@V$VP&BX*2
M[%\N<NL1</L!!'V"RDRQ"I5J5MEHSP*)[Y^A]@3TTQ[\L4L!?57)5<O]TT_6
MLY^*)<_67KH.*2MI6U6;0>?*4<MR=;O:_ET5=<>XS?XYAE"Y:V_WL<6$\+Q7
M4 NJS]#WP917*G0^U<C/9L,T+1)106ZH%S,2X3X(KOE(G8Q]6%]#,*"!"SB
M5;J"!]NTVDEO<AZ@*?@-Q 6/!E\^]VI ;IT]QOEVIT?OM$&O1)S?$C\&Q &/
ME_3HR\779<P6Z<\$=;0+K<4?^PKL!D4?N)AK$%P_:^G3M3EQF<-]ZLG7AEF<
M21#[;JC2YKTF;QDCJV;WVK5>V\[FF$GS8)/$9?+HYV%3_WW@_"%@9_C%  VI
M!6&<4P1NP>2T<'YQ]B5Z:!NC5KO1[SXU'4"^4GD]/)H".H#T=JW3;=?ZQV:C
M]7A@V#I;2!^8[W(SU-M>#S=%6 ]@/(,(U7M:=H:9@[L_FFE[QJA;Z_1ZC5[_
M\&D_>FZVOU5NMO.Z.7["N;D@:/].N1DO?9!3/_+")92123Z^C(4SI_)IIN/J
M(^I2.NZ;_\!TG+=R'RJPEG5<ZQYWGE2 >OQD7-""_1TFXX("L"JS:E8;2C.[
MU^B:_XQD7)AB^_M)QH5Y=[#@[K;;C?8=7'SOB<;J+*JS.HLJ;W6K,+K[)H!6
MJS&Z#A7UUCLFR?I?#G:>+FC!#M]>W6;DBFFLCQ.Z51L;J.L*9V7&H;,M;WAL
M1]$N'%TK;W5$CW@J'_H<CJ@B$M=0@GJVTZGUS&[--GN-_LZ2O6HGYBL9*]GR
M7YT:X<Y_NN>_UXP:=YE#?FWK9>,^O.&@(#^&R&XW[/87V.Q;!P6HX>&_)#3@
M9B6@73*("OK]8Z+M6_2\DP)7T$U4\DW0FQOZX0%\G"3OOSUX+YC2T'T;LQ^P
MU?8%C7R3>)L;]^'AVG_P>+OKNL2*INJ:4NX&! _P>B J=I%/?T.U_M(A>_,
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M,C$T.#9D,5]E>"UF:6QI;F=F965S+FAT;5!+!08      0 ! $L   "C#
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>tm2421486d1_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001267565</identifier>
        </entity>
        <period>
            <startDate>2024-08-13</startDate>
            <endDate>2024-08-13</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001267565</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-13</startDate>
            <endDate>2024-08-13</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001267565</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-13</startDate>
            <endDate>2024-08-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-138">S-8</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-139">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-140">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-141">0001267565</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-142">COLLEGIUM PHARMACEUTICAL, INC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-143">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_2" id="ixv-144">false</ffd:PrevslyPdFlg>
    <ffd:FormTp contextRef="rc" id="ixv-178">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-179">COLLEGIUM PHARMACEUTICAL, INC</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-180">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-181">Common Stock, $0.001 par value per share - Amended and Restated 2014 Stock Incentive Plan</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_1" id="ixv-182">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-183"
      unitRef="Shares">1274742</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-184"
      unitRef="USD">34.96</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-185"
      unitRef="USD">44564980.32</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-186"
      unitRef="pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-187"
      unitRef="USD">6577.79</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-188">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-189">Common Stock, $0.001 par value per share - 2015 Employee Stock Purchase Plan</ffd:OfferingSctyTitl>
    <ffd:Rule457aFlg contextRef="offrl_2" id="ixv-190">true</ffd:Rule457aFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_2"
      decimals="0"
      id="ixv-191"
      unitRef="Shares">318685</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-192"
      unitRef="USD">34.96</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-193"
      unitRef="USD">11141227.60</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-194"
      unitRef="pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-195"
      unitRef="USD">1644.45</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-196" unitRef="USD">55706207.92</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-197" unitRef="USD">8222.24</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-198" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-199" unitRef="USD">8222.24</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-200">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(3) Represents 1,274,742 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the Collegium Pharmaceutical, Inc. Amended and Restated 2014 Stock Incentive Plan (the "Stock Incentive Plan") on January 1, 2024, pursuant to an "evergreen" provision contained in the Stock Incentive Plan. Pursuant to such provision in the Stock Incentive Plan, as of the first day of each fiscal year, from January 1, 2016 until the expiration of the Stock Incentive Plan, the number of shares authorized for issuance under the Stock Incentive Plan is increased by a number of shares of Common Stock equal to 4% of the total number of outstanding shares of Common Stock on December 31st of the immediately preceding calendar year or such lesser number of shares of Common Stock as determined by the Board of Directors of the Registrant.
</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_2" id="ixv-201">(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this Registration Statement on Form S-8 shall be deemed to cover any additional shares of common stock, $0.001 par value per share (the "Common Stock"), of Collegium Pharmaceutical, Inc., a Virginia corporation (the "Registrant"), which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant. Pursuant to Rule 416(c) under the Securities Act, this registration statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan (the "ESPP").

(2) Estimated in accordance with Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Select Market on August 9, 2024.

(4) Represents 318,685 shares of Common Stock of the Registrant that were added to the shares authorized for issuance under the ESPP on January 1, 2024, pursuant to an "evergreen" provision contained in the ESPP. Pursuant to such provision in the ESPP, as of the first day of each fiscal year, from January 1, 2016 until December 31, 2025, the number of shares authorized for issuance under the ESPP is increased by a number equal to the least of (i) 400,000 shares of Common Stock, (ii) 1% of the outstanding shares of Common Stock on such date or (iii) an amount determined by the Board of Directors of the Registrant.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
